were maintained in growth medium or serum starved overnight before fixing and processing for EM.
There was no apparent difference in either the size or number of lysosomes when cells were incubated in serum free medium overnight (see arrows). Note also that there are no ultrastructural differences Video 2-Caveolin-1 and lysotracker labeled structures in starved cells move together indicating that they are colocalized.
Video 3-In control cells caveolin-1 and lysotracker remain separate. Caveosomes are clearly visible and as expected do not label with lysotracker.
Video 4-The association of caveolin-1 with LE/lysosomes is reversible but the dissociation does not appear to involve cavicles. Frames were captured every 1.3 sec. This is not the same video that was used to quantify reversal in Figure 4 A. That video was taken every 5 minutes to minimize overall bleaching.
Video 5-Treatment with progesterone, which interferes with the efflux of cholesterol from the LE/lysosomes, traps caveolin-1 at the LE/lysosomal membrane.
Video 6-U18666A blocks cholesterol efflux from LE/lysosomes and causes the redistribution of caveolin-1 to these membranes as well.
Video 7-Treatment of cells with low concentrations of cyclodextrin also result in the translocation of caveolin to the LE/lysosome.
Video 8-Cavicle movement away from a caveosome is clearly detectible with time-lapse imaging.
Video 9-FRAP analysis shows that caveolin-1 is not rapidly exchanging on the surface of the LE/lysosome but remains stably associated in serum starved cells.
